Costa Rica vs Peru: Death rate from cancer
Costa Rica
107.32 deaths per 100,000 people
in 2021
Peru
104.27 deaths per 100,000 people
in 2021
Costa Rica rank
83rd
Peru rank
86th
Death rate from cancer over time
- Costa Rica
- Peru
How they compare
Costa Rica currently reports 107.32 deaths per 100,000 people against 104.27 deaths per 100,000 people in Peru, a difference of 3.05 deaths per 100,000 people.
The two have swapped places 2 times across 22 shared years of data; in 2000 it was Costa Rica ahead.
Costa Rica ranks 83rd and Peru ranks 86th of 194 countries.
Costa Rica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 80.35 deaths per 100,000 people | 71.15 deaths per 100,000 people | 9.2 deaths per 100,000 people | Costa Rica |
| 2010s | 97.34 deaths per 100,000 people | 84.52 deaths per 100,000 people | 12.82 deaths per 100,000 people | Costa Rica |
| 2020s | 108.48 deaths per 100,000 people | 98.25 deaths per 100,000 people | 10.23 deaths per 100,000 people | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from cancer, Costa Rica or Peru?
- Costa Rica, at 107.32 deaths per 100,000 people against 104.27 deaths per 100,000 people in Peru as of 2021.
- What is the difference in death rate from cancer between Costa Rica and Peru?
- 3.05 deaths per 100,000 people, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Peru?
- 22 years are reported by both, from 2000 to 2021.
- How do Costa Rica and Peru rank globally for death rate from cancer?
- Costa Rica ranks 83rd and Peru ranks 86th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from cancer. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from malignant neoplasms in both sexes, per 100,000 people.